TrialDiabetes2016

Antithymocyte Globulin Plus G-CSF Combination Therapy Leads to Sustained Immunomodulatory and Metabolic Effects in a Subset of Responders With Established Type 1 Diabetes.

Michael J Haller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.